A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
Status:
Withdrawn
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to study the therapeutic effect of tetrabenazine MR in
children with Tourette's Syndrome, as measured by the improvement in total tic score of the
Yale Global Tic Severity Scale (YGTSS).
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.